Gca (eurosilicone)
Clinical trials sponsored by Gca (eurosilicone), explained in plain language.
-
10-year study tracks how often LunaXT breast implants break or harden
Disease control Recruiting nowThis study follows 650 women aged 18 to 65 who receive Eurosilicone LunaXT silicone breast implants for cosmetic augmentation or reconstruction after mastectomy. Researchers track how often the implants rupture or cause severe capsular contracture (hardening of scar tissue) over …
Sponsor: GCA (Eurosilicone) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
10-Year study tracks safety of new silicone breast implants
Knowledge-focused Recruiting nowThis study follows 60 women aged 18 to 65 who receive Nagor PERLE silicone breast implants for breast reconstruction, augmentation, or revision surgery. Researchers will monitor complications like capsular contracture (hardening) and implant rupture over 10 years. The goal is to …
Sponsor: GCA (Eurosilicone) • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC